02/08/2021

Smart Manufacturing für die Biotechnologie

Stuttgarter Start-up Variolytics: Analyseplattform beschleunigt Medikamentenentwicklung

01/29/2021

Live chat with surgeons at the operating table

Successful premiere - "Incisions and insights" as an online workshop (Stuttgart/Tübingen) - Last January saw the first event in 2021 from the well-known workshop series "Incisions and insights" take place online, due to the pandemic. Hosted by Dr. Klaus Eichenberg and Anja Reutter from BioRegio STE...
02/05/2021

CureVac Establishes European-Based Network to Ramp Up Manufacturing of its COVID-19 Vaccine Candidate, CVnCoV

Building an integrated European vaccine manufacturing network with experienced partners Managing supply chain risk by collaborating with several partners for each manufa...
02/05/2021

CureVac baut europäisches Netzwerk zur beschleunigten Produktion seines COVID-19-Impfstoffkandidaten CVnCoV auf

Aufbau eines integrierten europäischen Netzwerks zur Impfstoffherstellung mit erfahrenen Partnern Management von Lieferkettenrisiken durch Zusammenarbeit mit mehreren Pa...
02/04/2021

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of high med...
02/04/2021

CureVac erweitert Phase 1-Studie seines RNA-Kandidaten CV8102 beim fortgeschrittenen Melanom

Empfohlene Dosis für CV8102 ermittelt; Studienerweiterung soll Sicherheit, Verträglichkeit und Wirksamkeit bestätigen Fokus auf Melanom in fortgeschrittenem Stadium als ...
10/14/2020

Katairo Announces “Enrolment Completion”in STARTT Study of Remofuscin®

STARTT: Stargardt Remofuscin® Treatment Trial: A multi-national, multi-center, double-masked, placebo-controlled, proof of concept trial to evaluate the safety and efficacy of oral soraprazan inadults...